CD8A and neoplasm: While TILs were first restricted to CD8+ cytotoxic T cells, nowadays, they englobe all immune cells observed in the tumor, comprising effector and regulatory T lymphocytes, B lymphocytes, and NK cells in primary melanoma (133).